{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:39:41Z","timestamp":1764571181224,"version":"3.46.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with asymmetric, medication-refractory Parkinson\u2019s disease (PD) often continue to experience disabling motor symptoms despite optimized pharmacological management. Magnetic resonance\u2013guided focused ultrasound subthalamotomy (FUS-STN) has recently emerged as a promising, non-invasive alternative for improving motor function. However, its overall clinical efficacy and long-term safety remain the subject of active investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We systematically searched PubMed, Cochrane Library, Embase, Web of Science, and\n                      <jats:uri>ClinicalTrials.gov<\/jats:uri>\n                      from their inception to 30 November 2024. Prospective studies that assessed unilateral FUS-STN in patients with PD were included. Data were pooled using RevMan 5.3 for mean differences (MD) with 95% confidence intervals (CIs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four prospective studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f69) were included. Unilateral FUS-STN significantly reduced the Movement Disorders Society-Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS) Part III scores for the treated hemibody in both the off-medication [MD\u202f=\u202f\u221211.01, 95% CI (\u221212.23, \u22129.80),\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001] and on-medication states [MD\u202f=\u202f\u22126.51, 95% CI (\u22127.57, \u22125.42),\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001]. The MDS-UPDRS II (MD\u202f=\u202f\u22123.05,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01) and 39-item Parkinson\u2019s disease questionnaire summary index (PDQ-39SI) scores (MD\u202f=\u202f\u22126.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01) also improved. Levodopa equivalent daily dose (LEDD) was reduced in the short term (MD\u202f=\u202f\u2212149.5\u202fmg,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), although it was attenuated at 12\u202fmonths (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.09). No significant improvement was observed in MDS-UPDRS IV scores (MD\u202f=\u202f\u22123.29,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.64). In all included studies, adverse events (AEs) were frequent during and after the procedure, such as postoperative gait and speech disturbance, facial asymmetry, and dyskinesia. However, the majority of AEs were resolved during the 6\u201312\u202fmonth follow-up period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Unilateral FUS-STN may offer symptomatic benefits and a general safety profile in selected patients with asymmetric PD. Future investigations should emphasize large-scale, longitudinal, multicenter, and symptom-specific randomized controlled trials to assess the long-term benefits and risks of unilateral FUS-STN in PD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251002754<\/jats:uri>\n                      , identifier PROSPERO (CRD420251002754).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2025.1693035","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:26:55Z","timestamp":1764570415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of magnetic resonance\u2013guided unilateral focused ultrasound subthalamotomy for Parkinson\u2019s disease: a systematic review and meta-analysis of prospective studies"],"prefix":"10.3389","volume":"19","author":[{"given":"Bo","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang-hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-fa","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-shan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1007\/s10072-024-07617-2","article-title":"Safety and efficacy of unilateral focused ultrasound pallidotomy on motor complications in Parkinson's disease (PD): a systematic review and meta-analysis","volume":"45","author":"Abbas","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.30020","article-title":"Unilateral magnetic resonance-guided focused ultrasound lesion of the subthalamic nucleus in Parkinson's disease: a prospective study","volume":"39","author":"Armengou-Garcia","year":"2024","journal-title":"Mov. Disord."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"111159","DOI":"10.1016\/j.jocn.2025.111159","article-title":"Safety of focused ultrasound ablation in Parkinson's disease: a Meta-analysis of randomized controlled trials","volume":"135","author":"Balduino de Souza","year":"2025","journal-title":"J. Clin. Neurosci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s12311-023-01576-8","article-title":"Does vestibular motion perception correlate with axonal pathways stimulated by subthalamic deep brain stimulation in Parkinson's disease?","volume":"23","author":"Beylergil","year":"2024","journal-title":"Cerebellum"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/jamaneurol.2017.3098","article-title":"Safety and efficacy of focused ultrasound Thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial","volume":"74","author":"Bond","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.26945","article-title":"Illusions of self-motion during magnetic resonance-guided focused ultrasound thalamotomy for tremor","volume":"96","author":"Ciocca","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref8","year":""},{"key":"ref9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fsurg.2019.00076","article-title":"MRgFUS pallidothalamic tractotomy for chronic therapy-resistant Parkinson's disease in 51 consecutive patients: single center experience","volume":"6","author":"Gallay","year":"2019","journal-title":"Front. Surg."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1007\/s10072-021-05443-4","article-title":"Clinical application of magnetic resonance-guided focused ultrasound in Parkinson's disease: a meta-analysis of randomized clinical trials","volume":"42","author":"Ge","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/mds.29945","article-title":"Social cognition in Parkinson's disease after focused ultrasound Subthalamotomy: a controlled study","volume":"39","author":"Guida","year":"2024","journal-title":"Mov. Disord."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/B978-0-444-53497-2.00006-1","article-title":"Therapeutic stimulation versus ablation","volume":"116","author":"Hariz","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","article-title":"Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"349","author":"Krack","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2202721","article-title":"Trial of Globus Pallidus focused ultrasound ablation in Parkinson's disease","volume":"388","author":"Krishna","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1449973","DOI":"10.3389\/fneur.2025.1449973","article-title":"Ameliorating motor performance and quality of life in Parkinson's disease: a comparison of deep brain stimulation and focused ultrasound surgery","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41531-022-00332-9","article-title":"Neuroimaging signatures predicting motor improvement to focused ultrasound subthalamotomy in Parkinson's disease","volume":"8","author":"Lin","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/jnnp-2023-331211","article-title":"Unilateral focused ultrasound subthalamotomy in early Parkinson's disease: a pilot study","volume":"95","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1056\/NEJMoa2016311","article-title":"Randomized trial of focused ultrasound Subthalamotomy for Parkinson's disease","volume":"383","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e1395","DOI":"10.1212\/WNL.0000000000206771","article-title":"Prospective long-term follow-up of focused ultrasound unilateral Subthalamotomy for Parkinson disease","volume":"100","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2023","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(17)30403-9","article-title":"Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study","volume":"17","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10143-024-02948-2","article-title":"Magnetic resonance-guided focused ultrasound ventral intermediate thalamotomy for tremor-dominant Parkinson's disease: a systematic review and meta-analysis","volume":"47","author":"Monteiro","year":"2024","journal-title":"Neurosurg. Rev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"106040","DOI":"10.1016\/j.parkreldis.2024.106040","article-title":"MR-guided focused ultrasound in movement disorders and beyond: lessons learned and new frontiers","volume":"122","author":"Natera-Villalba","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMe2031151","article-title":"Parkinson's disease\u2014what\u2019s the FUS?","volume":"383","author":"Perlmutter","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual. Life Res."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/mds.20914","article-title":"Minimal clinically important change on the unified Parkinson's disease rating scale","volume":"21","author":"Schrag","year":"2006","journal-title":"Mov. Disord."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat. Methods Med. Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1301240","DOI":"10.3389\/fneur.2023.1301240","article-title":"Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson's disease: a systematic review and meta-analysis","volume":"14","author":"Tian","year":"2023","journal-title":"Front. Neurol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"106023","DOI":"10.1016\/j.parkreldis.2024.106023","article-title":"Focused ultrasound therapy: back to the future","volume":"121","author":"Verhagen Metman","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-021-03820-9","article-title":"Focused ultrasound: growth potential and future directions in neurosurgery","volume":"156","author":"Zhang","year":"2022","journal-title":"J. Neuro-Oncol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1693035\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:26:57Z","timestamp":1764570417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1693035\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":42,"alternative-id":["10.3389\/fnins.2025.1693035"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1693035","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1693035"}}